MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 05-16-2026
Radius Health ROCE Ratio 2011-2026 | RDUS
Annual ROCE Ratio Radius Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.53 | 66.65 | -71.08 | -84.84 | -60.99 | -60.13 | -21.48 | -67.6 | 298.68 | -784.77 | -73.01 | 12.12 | 15.33 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 298.68 | -784.77 | -62.28 |
Quarterly ROCE Ratio Radius Health
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.19 | 15.19 | 20.43 | 23.76 | 18.55 | 17.96 | 44.91 | 82.26 | 76.05 | 178.48 | 34960.68 | 34791.87 | 34749.28 | 34701.77 | 34551.95 | -259.15 | -124.4 | -142.6 | -128.27 | -102.84 | -73.35 | -86.58 | -79.68 | -56.14 | -34.17 | -39.63 | -38.24 | -34.83 | -25.19 | -96.37 | -125.35 | -109.5 | -101.62 | -95.02 | -16.33 | 26.99 | 22.99 | 32.09 | 36.18 | 37.54 | 28.65 | 36.97 | 46.35 | 39.88 | 31.02 | 8.32 | 18.49 | 4.21 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 34960.68 | -259.15 | 3601.02 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-73.94 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-5.51 | $ 5.59 | -0.27 % | $ 83 M | USA |
 |
HEXO Corp.
HEXO
|
-340.37 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-33.39 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-79.15 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-207.12 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-1.59 | $ 2.62 | -2.24 % | $ 1 B | Canada |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
58.18 | $ 38.91 | 3.37 % | $ 1.43 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
14.89 | $ 2.38 | 1.92 % | $ 302 M | USA |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 0.97 | -2.64 % | $ 104 M | Canada |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 22.87 | -0.52 % | $ 1.06 B | USA |
 |
Aurora Cannabis
ACB
|
0.81 | $ 3.02 | -0.63 % | $ 166 M | Canada |
 |
Solid Biosciences
SLDB
|
-90.02 | $ 7.18 | 0.56 % | $ 628 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 1.13 | 3.21 % | $ 1.4 M | USA |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.66 | $ 1.03 | -2.36 % | $ 98.2 M | Canada |
 |
Tilray
TLRY
|
-41.31 | $ 5.04 | 1.1 % | $ 3.11 B | Canada |
 |
Evolus
EOLS
|
141.36 | $ 6.67 | -0.89 % | $ 430 M | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.41 | -1.06 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
19.15 | $ 8.28 | -0.48 % | $ 443 M | USA |
 |
Veru
VERU
|
-135.01 | $ 3.1 | 3.47 % | $ 45.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-39.01 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-29.93 | $ 0.69 | 0.89 % | $ 2.78 M | USA |
 |
Assertio Holdings
ASRT
|
-22.92 | $ 23.5 | 0.09 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-265.79 | - | - | $ 5.07 M | USA |
 |
Bausch Health Companies
BHC
|
-327.26 | $ 5.01 | -0.89 % | $ 1.86 B | Canada |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-68.31 | $ 6.59 | -0.9 % | $ 260 M | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
40.43 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-32.55 | $ 4.2 | -0.71 % | $ 210 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
-18.1 | $ 16.36 | -0.7 % | $ 19.1 B | USA |
 |
Zomedica Corp.
ZOM
|
-73.1 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-12.68 | $ 0.66 | 5.44 % | $ 23.7 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.24 | $ 0.76 | 2.34 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
-16.33 | $ 2.29 | 4.18 % | $ 26.5 M | USA |